Web, Payments, Bytes & Ventures

WPBV Radio

Tune into tech and money.

Isomorphic Labs

Isomorphic Labs funding: the Series C round announced on 17 November 2026, from the company’s own announcement.

Amount
$5 billion
Round
Series C
Announced
Led by
Greenoaks, Sequoia Capital (co-leads)
Category
AI models and agents

Isomorphic Labs announced a $5 billion Series C on 17 November 2026, co-led by Greenoaks and Sequoia Capital. Isomorphic Labs, based in London, is an AI company focused on designing and developing new medicines with its proprietary drug design engine, IsoDDE. Other investors named in the announcement: Andreessen Horowitz, Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund.

Use of funds. Mature IsoDDE, expand into new biology with more advanced models, build AI-led bioengineering infrastructure and take its drug candidates toward clinical trials.

Questions

How much did Isomorphic Labs raise?

$5 billion in a Series C, announced on 17 November 2026.

Who led Isomorphic Labs’ round?

Greenoaks and Sequoia Capital (co-leads).

What does Isomorphic Labs do?

Isomorphic Labs designs and develops new medicines with AI, using its drug design engine IsoDDE for internal programs and with partners.

See every round in the tech funding tracker, and read what a funding round does not tell you.

Company
Isomorphic Labs
Amount, USD million
5,000
Other investors
Andreessen Horowitz (a16z), Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek, UK Sovereign AI Fund
Headquarters
United Kingdom
Announcement
prnewswire.com
Sources
SourceLink
Isomorphic Labs announcementhttps://www.prnewswire.com/news-releases/isomorphic-labs-announces-5-billion-series-c-funding-302942062.html

Source: amounts, rounds, lead investors and valuations are as stated in the company’s or lead investor’s own announcement, linked under Sources on each round’s page.

WPBV Radio

What are you looking for?

Search by headline, topic or keyword.